All Medicines and Healthcare Products Regulatory Agency articles – Page 4
-
News
Safety regulators reviewing concerns about Babylon's 'chatbot'
Safety regulators are reviewing concerns raised about Babylon Healthcare’s symptom checker “chatbot” following multiple complaints, HSJ has learned.
-
News
NHS hit by seven-fold increase in bill for certain drugs
NHS commissioners were hit by a seven-fold increase in the bill for certain generic drugs in 2017-18, after some medicines were subject to massive price hikes.
-
HSJ Local
Four trusts looking into pharmacy joint venture
Trusts in Berkshire and Surrey are looking at creating a pharmacy joint venture modelled on their existing pathology service.
-
News
Revealed: Eight-fold increase in DH 'exit package' payments
The Department of Health and its executive agencies spent £39m on “exit packages” last year, following the departure of more than 700 staff.
-
Comment
Turbo charging AHSNs to spread health innovations
Liz Mear on how AHSNs will leverage new funding to locally assess the benefits of new technologies and support NHS uptake of those that deliver real benefits to patients
-
HSJ Local
Keogh unveils safety steps after patient dies from drinking alcohol gel
NHS England’s medical director is considering new safety measures for acute trusts after a patient died from drinking alcohol rub.
-
News
CCGs spending millions on drug that 'kills people'
The NHS is spending millions in prescriptions of a drug which is regarded as unsafe and was withdrawn from the UK market over 10 years ago, HSJ has been told.
-
News
NHS England warns of heart surgery infection risk
NHS England says patients will be warned they could be at low risk Twenty-eight known cases of mycobacterium chimaera infection including 15 people who have died Infection risk identified in other countries linked to heater/cooler devices NHS England is writing to thousands of patients who have had open ...
-
News
High Court rules against regulator in pharma transparency case
A High Court judge has concluded that the Health Research Authority acted unlawfully in applying new transparency rules on pharmaceutical companies carrying out clinical trials.
-
News
Making NICE guidelines mandatory ‘counterproductive’, says former chair
The National Institute for Health and Care Excellence’s former chair Sir Michael Rawlins has criticised NHS commissioners for ‘poorly implementing’ the body’s guidelines but said making them mandatory would be ‘counterproductive’.
-
News
MHRA introduces early access scheme
Severely-ill patients will soon have access to new medicines years before they are given the green light for widespread use.
- Previous Page
- Page1
- Page2
- Page3
- Page4
- Next Page